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a therapy. Protection and cure have been associated with increased 
antigen-specific T H ~  cell responses. The role ofsecretory IgA and/or 
of IgG in the protection of the gastric mucosa remains however un- 
clear. We also showed that oral immunization with urease was safe 
in H. pylori-infected humans and could reduce the density of infec- 
tion. Further developments include the use less toxic adjuvants or of 
live vaccine vectors, the determination of the optimal immunization 
procedure to induce protection of the gastric mucosa as well asthe 
use of combinations of antigens. 
The Carbapenem Decade 
Comparative Evaluation of Carbapenems in 
lntra-Abdominal Infections 
A. Basoli, V Speranza. Clinica Chiturgica II. Universitd "Ln Sapienzu", 
Policlinuo Umberto I. 00161 Rome, Italy 
Objectives: Imipenem/dastatin (I/C) has been shown to be highly 
effective as monotherapy in the treatment of intra-abdominal mfec- 
dons. Meropenem (Me), a carbapenem with an I/C like spectrum 
of activity, has been reported in two recent clinical trials (in one I/C 
3 grvs Me 3 grday and in the other I/C 1.5 grvs Me 1.5 gr day) 
to have as good a safety and efficacy profile as I/C. The aim of ths 
paper is to compare the results obtained in the three trials. 
Methods: We undertook an open label, prospective, randomized, 
parallel multicenter study to compare the efficacy and tolerabLity 
of 1.5 gr of I/C with 3 gr of Me day. These dosages were chosen 
because: 1 Me is recommen$ed at 3 gr/day in intra-abdominal in- 
fections while I/C is effective at 1.5 gr, 2 I/C has greater activity 
on Enterococcus (four times higher). Of 287 patients enrolled in 20 
centers, 201 patients were evaluable (101 randomized to I/C and 
100 to Me). In the 86 (31.8%) non evaluable patients 94.1% were 
excluded owing to failure to recover susceptible pathogens. Compar- 
ative analysis shows that our patients were more severe than those in 
the other studes: fewer cases of appendicitis (15% vs 35% and 73%) 
and more cases in the moderate severe group according to APACHE 
I1 score. 
Results: Although the Jirucal and bacteriological outcome were 
not s'gtllficantly Merent, at the staft of our study with I/C, 9 
pathogens sensitive to I/C were resistant to Me and of the 15 En- 
terococcus sp. sensitive to I/C 6 were resistant to Me. Furthermore, 
in our study both the mean time to defervescence (1.83 days vs 2.46 
days p = 0.046) and the average duration of therapy (6.7 days vs 4.2 
days = 0.019) were sigruficantly shorter in the I/C group. Seizures 
did not occur in any of the trials even when 1 gr/8 hr of I/C was 
employed. 
Conclusions: The fact that I/C was clinically efficacious at half 
the dosage of Me and required a shorter duration of treatment, even 
though the patients treated with I/C appeared to be more severe that 
those in the Me group clearly suggests that I/C is sigruficantly more 
cost effective, at least with respect to the cost of the antibiotic itself. 
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Clinical sciences Building, 840 South Wood Street, Chiago, IL 
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Gram negative pathogens harboring extended-spectrum beta-lac- 
tamases (ESBLs) are becoming an increasing therapeutic problem 
globally. We have recently published an analysis of an in-vim re- 
sistance survey among 33,869 gram negative organisms fivm 396 
intensive care units in the United States. The prevalence of cef- 
tazidime-resistance among Klebsiella is0late.s in this survey rose fivm 
3.6% to 14.4% between 1990 and 1993 (Itokazu. Clin Inject Dis  
1996; 23: 779). 
A molecular epidemiologic investigation of an epidemic of 31 
bloodstream infections with multi-resistant Mebsielh and E. coli in a 
university hospital in Chicago revealed that most cases occurred in 
debilitated nursing home (NH) patients who were instrumented, had 
hlgh APACHE scores, and had recently been treated with antibi- 
otia, especially extended-spectrum cephalosporins (ESCs). In h 
outbreak and in a similar epidemic reported in 1993 &om a hospital 
in New York City, patiena treated wth  imipenem and/or amikacin 
had a higher sunrival rate than those treated with ESCs (Schiappa. 1 
Infea Dis 1996; 174  529). 
We are currently investigating a city wide outbreak of 
ESBL-producing pathogens among NH patients admitted to 6 
Chicago hospitals mediated by a common 54 Kb plasmid. Prior 
exposure to oral TMP-SMX and/or quinolones was a risk factor for 
colonization mth an ESBL-producer in ths study. 
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I S114 I The Economics of a New Delivery System 
H. Robays. Pharmacy Services UZG, De P i n t e h n  185, B-9000, 
GEN?; Belgium 
Objectives: to explain the Werencies between the Werent prepa- 
ration methods of IV drugs. 
Methodology: the conventional methods, i.e. syringe-needle and 
m f e r t  needle were compared with the Monovial @, a drug con- 
tainer with an integrated transfer system. In a first step all relevant 
costs of each method were established and the cost of each activity 
was calculated. In a third step these global costs were calculated for 
a sample of 10 drugs commonly used in the hospital. Finally the 
opinion of 31 nurses was examined by means of two open and 9 
score statements. 
Results: the transfer-needle method was the most expensive way 
to prepare drugs for IV administration (31.73 BEF) followed by the 
syringe-needle method (23.23 BEF). M o n o d  @ is the cheapest 
method for the preparation of IV drug administration (10.71 BEF). 
In the general opinion of the nurses, the preparation of IV drugs by 
means of the Monovial @ is an improvement in terms of speed, ease 
of use and reduces of the amount of waste, d e t y  and aepsy. 
Conclusion: new administration dmces can diminish prepara- 
tion time. 
I S115 I Microbiological Overview of the Carbapenems 
D.M. Livermore. St. Burtholomew's 6 the Royal London .School of 
Medicine G Dentise, London E l  2AD, United Kingdom 
The carbapenems are formidable antimicrobials, with broader spec- 
tra than any other B-lactam. Of the compounds available, imipenem 
has been widely used for 12 years and meropenem for 2; pa- 
nipenem is used in Japan, not elsewhere. Meropenem is the 
most active apns t  gram-negative bacteria, imipenem the most ac- 
tive against agatnst gram-positive cocci. All rerain activity against 
AmpC-derepressed enterobacteria and those with ESBLs. To date, F! 
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aeruginosa has been the sole species prone to develop imipenem resis- 
tance, acheved by loss of a speclhc porin, OprD. Loss of OprD 
also raises the MIC of meropenem, though rarely above break- 
point, but does not affect MICs of penicilLns or cephalosporins. 
By contrast, MICs of meropenem, p e n i c h  and cephalosporins - 
not those of imipenem - are raised for I! amginosa strains with in- 
creased function of the MexA-Me&-OprM multi-drug efflux sys- 
tem. New modes of carbapenem resistance are emerging and may 
present future problems: IMP-1, a plasmidic zinc b-lactamase, is 
spreading in gram-negative rods in Japan, and various modes of re- 
sistance occur in Acinetobacter spp. New carbapenems-sanfetrinem 
and L-749,345- are in advanced development. Sanfetrinem, an 
oral agent, has anti-gram positive activity resembling inupenem 
but is slightly less active vs. gram-negative pathogens; L-749,345 
has s d a r  activity to meropenem, except us. Z? aeruginosa, but has 
pharmacokinetics resembling cefuiaxone. Experimental carbapen- 
ems bind PBP-2‘ of MRSA, and have MICs 50.03 mg/L for 
highly penicillin-resistant pneumococci. No described carbapenem 
escapes IMP-1 p-lactamase, but it may be overcome with new in- 
hibitors. 
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During the last decade, the industrialized nations have experienced a 
well-publicized tuberculosis (TB) epidemic. By the same token, the 
occurrence of new species of nontuberculous mycobacteria (NTM) 
have challenged the microbiology laboratories’ capability to provide 
accurate results in a timely fashion. Furthermore, the economic cli- 
mate pun an additional spin on the charge placed on laboratories 
providing clinical services. Once a diagnosis of mycobacterial &ease 
in a patient is suspected, a series of interactions between the clinician 
and the laboratory are set into motion. The following three topics 
require attention: 1) In patients with acid-fast bacilli smear-positive 
sputum specimens diagnosed for the first time, the Meentiation 
between TB and NTM is imperative (respiratory isolation, adequate 
drug regimen, and contact investigation); 2) in areas with increased 
drug resistant TB susceptibility testing results, especdy for rifampin, 
are paramount; and 3) the emergence of chcaIly sigruficant NTM, 
especially in immuno-comprised hosts, poses an additional challenge 
for patient care. The foundations of the clinical mycobacteriology 
laboratory of the next millennium are: a) testing and prioritizing 
hgh-quality specimens, b) joining the acid-fast network to provide 
accurate results in a timely fasluon, and c) bridgmg the gap between 
physicians, laboratorians, and public health officds in order to im- 
prove the service rendered for our patients. As the adage goes “That 
which is worth doing is worth doing right”. 
LS117 I Mycobacterial Screening of Non-Blood and 
Blood Specimens Using (Semi) Automated 
Mycobacteria Detection Systems 
R. Freeman. Newciz.de Public Health Luboratoy, Newca.de upon Tyne, 
UK 
The use of liquid media for primary isolation has always had a place 
in mycobacteriology. However, the lnherent dangers ofliquid culture 
(compared with solid cultures), the increased difficulties with con- 
tamination and the laboriousness of observation for signs of p w t h  
have all dictated that liquid culture be reserved for a small minority 
of specimens and particularly those fiom ordmarily sterile sites such 
as the spinal fluid. 
Modern approaches to liquid cultures, partly driven by earlier 
work on non-mycobacterial organisms, have resulted in the develop- 
ment of automated or semi-automated liquid culture systems which 
are securely contained and highly selective. The addition of highly 
sensitive growth monitoring technology has ensured that the pres- 
ence of mycobacteria in these systems can be detected at far shorter 
intervals than hitherto. In many instances it is now possible to grow 
mycobacteria, including Mycobaderium tuberculosis, within 2 weeks of 
specimen receipt. 
Several Merent approaches have been developed. T h  presen- 
tation will contrast and compare these, looking particularly at the 
speed and accuracy of detection, the incidence of contamination, 
the ease of usage and the immediate usefulness of the detected liquid 
culture biomass for further investigations (genetic probe identifica- 
tions, antibiotic susceptibihties, and so on). The presentation will 
also consider the optunal use for these novel but expensive methods, 
using data generated by a large ongoing study, and balancing issues 
of cost and safety against the undoubted advantages of this important 
advance in mycobacteriology. 
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L. Heifets, F! Lindhoh-Levy, T. Sanchez, J. Brennan, L. Gomelsky. 
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Objectives: To evaluate the liquid media-based systems for rapid 
indirect drug susceptibihty tests with M .  tuberculosis. 
Methods: New systems for mycobacterial cultivation, h4B/BacT 
fiom Organon T e e ,  ESP fiom Difco and MGIT &om Bec- 
ton-Dickinson, were evaluated in comparison with 7 H l l  agar and 
Results: All methods tested are suitable for isolation of mycobac- 
teria and for indirect susceptibility testing with M .  tuberculosis, but 
the critical concentrations ofsome drugs require further adjustments. 
Timing for isolation and the indirect susceptibility test in new sys- 
tems upds sigdicantly shorter than on agar plates, but it was 2 to 5 
days longer than in the BACTEC-460 system. 
Conclusions: Liquid media systems have the potential to expe- 
dite the diagnosis of tuberculosis and detection of drug resistance. 
The added cost can be justhed only for initial specimens fiom new 
patients if tested in large laboratories. Indmect testing in any liquid 
media should not replace the direct test on 7Hl l  agar plates for 
AFB-positive specimens. 
BACTEC-460. 
Molecular technologies in diagnostic 
mycobacteriology 
A. Telenti. Institutefor Medial Microbiolon, University $ Bern, 
Switzerland 
A number of molecular techniques have recently been made avail- 
able in mycobacteriology. Various key questions should be answered 
before routine implementation of these tools: 
(a) which techniques are reliable, and for which purpose? 
(b) who should perform them? 
(c) will they influence patient management? 
(d) are they cost-effective for the proposed setting? 
